Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population

BACKGROUND AND OBJECTIVES: Apolipoprotein E (APOE) gene polymorphisms have been examined extensively in multiple global populations particularly due to their crucial role in lipid metabolism and cardiovascular disease. However, the overall contribution of APOE polymorphisms in type 2 diabetes (T2D)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes Complications
Autors principals: Sapkota, Bishwa, Subramanian, Anuradha, Priamvada, Gargi, Finely, Hadley, Blackett, Piers R., Aston, Christopher E., Sanghera, Dharambir K.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656127/
https://ncbi.nlm.nih.gov/pubmed/26318958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2015.07.025
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars